Skip to content
Home › 13F recaps › Q3 2026 › CVS

Which funds bought or sold CVS in Q3 2026?

Cvs Health Corp. 10 funds bought, 14 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$1.8B.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold CVS, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (10)

FundChangeEst. $Now
Arrowstreet
Quant & multi-strategy
Added+90%+$391M$825M
Wellington
Asset manager
Added+8.5%+$247M$3.1B
Renaissance
Quant & multi-strategy
Added+517.7%+$196M$233M
QRT
Quant & multi-strategy
Added+177.7%+$175M$273M
Geode
Index giant
Added+3.4%+$87M$2.6B
CPP Investments
Sovereign & pension
Added+36.4%+$69M$260M
Man Group
Quant & multi-strategy
Added+277.6%+$54M$73M
Northern Trust
Bank & broker
Added+4.5%+$44M$1.0B
CalPERS
Sovereign & pension
Added+13.8%+$27M$220M
Maverick
Hedge fund
New+$2M$2M

Sold (14)

FundChangeEst. $Now
GQG
Growth / crossover
Trimmed-64.6%−$441M$241M
Viking
Hedge fund
Sold out−$379M—
Citadel
Quant & multi-strategy
Trimmed-83%−$342M$70M
Dodge & Cox
Value investor
Trimmed-7.9%−$340M$3.9B
Glenview
Hedge fund
Trimmed-73.5%−$304M$110M
Capital Research
Asset manager
Trimmed-10.2%−$212M$1.9B
Point72
Quant & multi-strategy
Sold out−$203M—
RBC
Bank & broker
Trimmed-22.2%−$162M$567M
Holocene
Hedge fund
Trimmed-57.2%−$147M$110M
Pzena
Value investor
Trimmed-12.5%−$126M$882M
AllianceBernstein
Asset manager
Trimmed-29.9%−$83M$194M
Adage
Hedge fund
Trimmed-41%−$58M$83M
Tudor
Hedge fund
Sold out−$38M—
Oakmark
Value investor
Trimmed-22.4%−$6M$22M

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.